Company news

Scholar Rock Holding Corporation news in 2023

Scholar Rock Holding Corporation's news releases, calls and decks from 2023, newest first.

View company

Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 18, 2023

Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress

November 6, 2023

Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability

November 2, 2023

Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023

October 22, 2023

Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting

October 18, 2023

Scholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

October 15, 2023

Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders

October 10, 2023

Scholar Rock Announces Proposed Public Offering of Common Stock

October 10, 2023

Scholar Rock Announces Pricing of Upsized Public Offering of Common Stock

October 10, 2023

Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial

September 18, 2023

Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress

August 8, 2023

New 36-Month Apitegromab Extension Data Reinforce Long-Term Substantial and Sustained Improvement of Motor Function in Phase 2 TOPAZ Trial Patients with Nonambulatory Spinal Muscular Atrophy

June 29, 2023

Scholar Rock to Present at the Jefferies Healthcare Conference

May 31, 2023

Scholar Rock Reports First Quarter 2023 Financial Results and Highlights Business Progress

May 8, 2023

Scholar Rock to Present New Data Evaluating Apitegromab at 36 Months from the Phase 2 TOPAZ trial at the 2023 Annual Cure SMA Conference

May 7, 2023

Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors

April 9, 2023

Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress

March 6, 2023

Scholar Rock to Present 24-Month Data from the Phase 2 TOPAZ trial at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

February 28, 2023

Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference

February 26, 2023

Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer

February 5, 2023

Scholar Rock Provides Corporate Update and Highlights Priorities for 2023

January 8, 2023

Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 2, 2023

Calls in 2023

Decks in 2023